Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1048 |
---|---|
Product Name | Anti-Human IL1B Recombinant Antibody(Gevokizumab) |
Molecular Name | Gevokizumab |
Alias | Anti-IL1B Recombinant Antibody, Research Grade Gevokizumab |
CAS Number | 1129435-60-4 |
Target | IL1B[Homo sapiens] |
Isotype | IgG2 Kappa |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, FCM, IP, FuncS, IF, Neut, ICC |
Buffer | PBS, pH7.5 |
Background | Gevokizumab is an experimental monoclonal antibody, developed by XOMA Corporation, with allosteric modulating properties. Gevokizumab binds to interleukin-1 beta (IL-1 beta), a pro-inflammatory cytokine, and downmodulates the cellular signaling events that produce inflammation. IL-1 beta has been implicated in cardiovascular conditions, lung cancer, and auto-inflammatory diseases. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |